Table 2.
Summary of clinical findings
| Age | Gender | BCVA | BCVA | Type 1 flecks | Type 1 flecks | Type 2 flecks | Type 2 flecks | Foveal PR loss | Foveal PR loss | |
|---|---|---|---|---|---|---|---|---|---|---|
| RE | LE | RE | LE | RE | LE | RE | LE | |||
| Case 1 | 50 | M | 20/40 | 20/50 | X | X | – | X | – | X |
| Case 2 | 39 | F | 20/20 | 20/20 | X | X | X | – | – | – |
| Case 3 | 41 | F | 20/25 | 20/25 | X | X | – | – | – | – |
| Case 4 | 29 | F | 20/20 | 20/25 | X | X | – | – | – | – |
| Case 5 | 40 | M | 20/25 | 20/50 | X | X | X | X | – | X |
| Case 6 | 28 | M | Not included | 20/20 | Not included | X | Not included | – | Not included | – |
| Case 7 | 29 | M | 20/400 | 20/400 | – | – | – | – | X | X |
| Case 8 | 39 | M | 20/125 | 20/125 | X | X | X | X | X | X |
| Case 9 | 28 | M | 20/20 | 20/20 | X | X | – | – | – | – |
| Case 10 | 30 | M | 20/200 | 20/200 | – | – | – | – | X | X |
| Case 11 | 40 | M | 20/25 | 20/50 | X | X | X | X | – | X |
| Case 12 | 28 | F | 20/40 | 20/50 | X | X | – | – | – | – |
| Case 13 | 38 | F | 20/25 | 20/25 | X | X | X | – | – | – |
| Case 14 | 51 | M | 20/20 | 20/25 | X | X | – | X | – | X |
| Case 15 | 38 | M | 20/160 | 20/160 | X | X | X | X | X | X |
| Case 16 | 42 | F | 20/20 | 20/20 | X | X | – | – | – | – |
Abbreviations: M, male; F, female; RE, right eye; LE, left eye; BCVA, best corrected visual acuity; PR, photoreceptor.